Mirum Pharmaceuticals (MIRM) Times Interest Earned (2020 - 2026)
Mirum Pharmaceuticals' quarterly Times Interest Earned came in at -$218.33 in Q1 2026, down 5070.9% year-on-year from $4.39 in Q1 2025, and down 17100.24% quarter-over-quarter from -$1.27 in Q4 2025.
Mirum Pharmaceuticals has reported Times Interest Earned for 7 years, with the latest figure at -$218.33 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 5070.9% year-over-year to -$218.33; the trailing twelve-month figure through Mar 2026 stood at -$55.27 (down 937.79% YoY), and the FY2025 full-year result was -$1.54, up 74.87% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$218.33, down from -$1.27 in the prior quarter.
- The five-year high for Times Interest Earned was $0.72 in Q3 2025, with the low at -$218.33 in Q1 2026.
- Average Times Interest Earned over 5 years is -$18.29, with a median of -$6.79 recorded in 2024.
- Year-over-year, Times Interest Earned soared 120.41% in 2025 and sank 5070.9% in 2026.
- Tracing MIRM's Times Interest Earned over 5 years: stood at -$7.84 in 2022, then fell by 16.7% to -$9.15 in 2023, then advanced by 26.0% to -$6.77 in 2024, then jumped by 81.24% to -$1.27 in 2025, then plunged by 17100.24% to -$218.33 in 2026.
- The last three Times Interest Earned figures came in at -$218.33 (Q1 2026), -$1.27 (Q4 2025), and $0.72 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | -218.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -218.33 |
| Dec 31, 2025 | -1.27 |
| Sep 30, 2025 | 0.72 |
| Jun 30, 2025 | -1.39 |
| Mar 31, 2025 | -4.22 |
| Dec 31, 2024 | -6.77 |
| Sep 30, 2024 | -3.54 |
| Jun 30, 2024 | -6.79 |
| Mar 31, 2024 | -7.40 |
| Dec 31, 2023 | -9.15 |
| Sep 30, 2023 | -7.04 |
| Jun 30, 2023 | -6.51 |
| Mar 31, 2023 | -6.40 |
| Dec 31, 2022 | -7.84 |
| Sep 30, 2022 | -8.28 |
| Jun 30, 2022 | -8.11 |
| Mar 31, 2022 | -8.67 |
| Dec 31, 2021 | -12.10 |
| Sep 30, 2021 | -7.56 |
| Jun 30, 2021 | -7.83 |
| Mar 31, 2021 | -14.08 |
| Dec 31, 2020 | -110.30 |